Clinical trial
Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura
NCT00449540 · Neuralieve, Industry · Completed
Key facts
| NCT number | NCT00449540 |
|---|---|
| Title | Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura |
| Official title | Phase III Randomized Double-Blind Parallel Group Sham-Controlled Study Evaluating the Efficacy and Safety of Non-invasive Non-repetitive Transcranial Magnetic Stimulation (TMS) for the Acute Preemptive Treatment of the Aura Phase of Migraine Headache |
| Lead sponsor | Neuralieve, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Migraine With Aura |
| Intervention type | Device |
| Interventions | Active Transcranial Magnetic Stimulation (TMS) Device, Sham TMS Device |
| Enrollment | 201 |
| Start date | Aug 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Mar 20, 2007 |
| Last update posted | Aug 15, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: